Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Urology|July 8, 2026
External validation of the heidenreich criteria for patients with post-chemotherapy residual masses of non-seminomatous germ cell tumorFrancesco Claps, Miguel Ramírez-Backhaus, Álvaro Gómez-Ferrer, et al.
International Urology and Nephrology|August 21, 2021
Management of local recurrence after radical nephrectomy: surgical removal with or without systemic treatment is still the gold standard. Results from a multicenter international cohortMichele Marchioni, Petros Sountoulides, Maria Furlan, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 14, 2019
Ex-vivo confocal fluorescence microscopy for rapid evaluation of renal core biopsyM Carmen Mir, Bernardo Bancalari, Ana Calatrava, et al.
Urologic Oncology|September 29, 2022
Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomyFrancesco Claps, Pedro de Pablos-Rodríguez, Álvaro Gómez-Ferrer, et al.
European Urology Open Science|December 22, 2021
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium DatabaseKerri Beckmann, Aida Santaolalla, Jozien Helleman, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 6, 2021
Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomyFrancesco Claps, Miguel Ramírez-Backhaus, Maria Carmen Mir Maresma, et al.
Prostate International|August 13, 2021
Rebiopsy rate after transperineal or transrectal prostate biopsyJose L Marenco Jimenez, Francesco Claps, Juan C Ramón-Borja, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2018
Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling studyTim M Govers, Daphne Hessels, Virginie Vlaeminck-Guillem, et al.
BMC Cancer|September 13, 2015
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsyJose Rubio-Briones, Angel Borque, Luis M Esteban, et al.
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
Pageof 3